Metabolite details
Reactome pathways
- R-HSA-1430728 - Metabolism
- R-HSA-1483101 - Synthesis of PS
- R-HSA-1483206 - Glycerophospholipid biosynthesis
- R-HSA-1483257 - Phospholipid metabolism
- R-HSA-1614603 - Cysteine formation from homocysteine
- R-HSA-1614635 - Sulfur amino acid metabolism
- R-HSA-1643685 - Disease
- R-HSA-1660661 - Sphingolipid de novo biosynthesis
- R-HSA-196757 - Metabolism of folate and pterines
- R-HSA-196849 - Metabolism of water-soluble vitamins and cofactors
- R-HSA-196854 - Metabolism of vitamins and cofactors
- R-HSA-2408508 - Metabolism of ingested SeMet, Sec, MeSec into H2Se
- R-HSA-2408522 - Selenoamino acid metabolism
- R-HSA-2408557 - Selenocysteine synthesis
- R-HSA-352230 - Amino acid transport across the plasma membrane
- R-HSA-379716 - Cytosolic tRNA aminoacylation
- R-HSA-379724 - tRNA Aminoacylation
- R-HSA-379726 - Mitochondrial tRNA aminoacylation
- R-HSA-382551 - Transport of small molecules
- R-HSA-392499 - Metabolism of proteins
- R-HSA-425407 - SLC-mediated transmembrane transport
- R-HSA-428157 - Sphingolipid metabolism
- R-HSA-442660 - SLC-mediated transport of neurotransmitters
- R-HSA-556833 - Metabolism of lipids
- R-HSA-5619044 - Defective SLC6A19 causes Hartnup disorder (HND)
- R-HSA-5619094 - Variant SLC6A14 may confer susceptibility towards obesity
- R-HSA-5619102 - SLC transporter disorders
- R-HSA-5619115 - Disorders of transmembrane transporters
- R-HSA-5659735 - Defective SLC6A19 causes Hartnup disorder (HND)
- R-HSA-71291 - Metabolism of amino acids and derivatives
- R-HSA-72766 - Translation
- R-HSA-977347 - Serine metabolism
- R-HSA-9958863 - SLC-mediated transport of amino acids
Observed in studies
- Biological effect of chronic mistranslation in mammalian cells
- Metabolomic responses to long-term salt stress in related Lotus species (A)
- Metabolomics analysis identifies metabolites associated with systemic acquired resistance in Arabidopsis
- Metabolomic responses to long-term salt stress in related Lotus species (C)
- Metabolic cooperation and spatiotemporal niche partitioning in a kefir microbial community; Interaction between the kefir isolates Lactococcus lactis and Acetobacter fabarum (GC-MS)
- Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Escherichia coli assays)
- The response of Chlamydomonas reinhardtii to nitrogen deprivation: a systems biology analysis
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Metabolomics identifies the intersection of phosphoethanolamine with menaquinone- triggered apoptosis in an in vitro model of leukemia
- Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Klebsiella pneumoniae assays)
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pneumoniae assays)
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pyogenes assays)
- Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
- Metabolic characterization of the natural progression of chronic hepatitis B (Biogenic amine and Acyl-carnitine assays).
- SARS-CoV-2-reprogrammed metabolism and autophagy reduction uncover host-targeting antivirals
- Microbial Diversity and Non-volatile Metabolites Profile of Low-Temperature Sausage Stored at Room Temperature
- Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
- Multiomics of tomato glandular trichomes reveals distinct features of central carbon metabolism supporting high productivity of specialized metabolites
- Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 21)
- Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
- Multiple biochemical indices and metabolomics of Clonorchis sinensis provide a novel interpretation of biomarkers
- Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
- Gut microbiome drives individual memory variation in bumblebees
- The Manchurian Walnut Genome: Insights into Juglone and Lipid Biosynthesis.
- Appropriate taxonomic classification of intestinal microbiome by 16S rRNA gene targeting metagenomic approach
- Multi-omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer
- Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
- Transcriptional Shift and Metabolic Adaptations during Leishmania Quiescence Using Stationary Phase and Drug Pressure as Models
- Proteomic and metabolic changes in cancer cells after alternation of SHMT2 expressions
- Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
- Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study
- Altered fecal metabolomics and potential biomarkers of psoriatic arthritis differing from rheumatoid arthritis
- Homeostasis of the biosynthetic E. coli metabolome
- Mining for metabolic responses to long-term salt stress: a case study on the model legume Lotus japonicus (A)
- Comparative Analysis of Host Metabolic Alterations in Murine Malaria Models with Uncomplicated or Severe Malaria
- Mining for metabolic responses to long-term salt stress: a case study on the model legume Lotus japonicus (B)
- Cardiac disruption of SDHAF4-mediated mitochondrial complex II assembly promotes dilated cardiomyopathy.
- Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
- Integrated Metabolomics and Transcriptomics Analyses Reveal Anthocyanin and Carotenoid Biosynthesis Involved in Color Development in Willow Bark
- Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
- Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis
- Mining for metabolic responses to long-term salt stress: a case study on the model legume Lotus japonicus (C)
- Bile acid is a significant host factor shaping the gut microbiome of diet induced obese mice (untargeted metabolome profile assay)
- Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
- GABA regulates IL-1β production in macrophages
- Transcriptomics and metabolomics analysis reveal the anti-oxidation and immune boosting effects of mulberry leaves in growing mutton sheep
- Regulatory actors and alternative routes for Arabidopsis seed germination are revealed using a pathway‐based analysis of transcriptomic datasets
- Extracellular-acidosis restricts one-carbon metabolism and preserves T cell stemness
- TGF-β uncouples glycolysis and inflammation in macrophages and controls the survival during sepsis
- Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui
- Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
- Changing environments and genetic variation: inbreeding does not compromise short-term physiological responses
- Decreased abundance of type III secretion systeminducing signals in Arabidopsis mkp1 enhances resistance against Pseudomonas syringae
Observed in differential profiles
- rps2_wildtype_vs_rps2_A226Y
- Lotus_japonicus_MG20_Control_vs_Treatment
- Local_Leaf_Control_vs_Local_Leaf_Avr
- G1_Lotus_japonicus_var_MG20_Control_vs_G2_Lotus_japonicus_var_MG20_Treatment
- Milk_0h_vs_Whey_72h
- non_COVID_19_healthy_vs_non_critical_COVID_19
- RPMI_B36_vs_Pooled_Sera_B36
- 0h_vs_24h
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- G1_Jurkat_Negative_Control_0h_vs_G7_Jurkat_Menaquinone_72h
- G1_Klebsiella_pneumoniae_AJ218_RPMI_vs_G2_Klebsiella_pneumoniae_AJ218_Pooled_sera
- G1_Klebsiella_pneumoniae_AJ218_RPMI_vs_G2_Klebsiella_pneumoniae_AJ218_Pooled_sera
- G1_Pooled_Sera_Blood_4559_vs_G2_RPMI_Glucose_Blood_4559
- G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448
- G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448
- Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
- Control_vs_Lipopolysaccharide_stimulated
- Control_vs_nsPEF_7_day
- WT_vs_WT_Aco
- Control_vs_Immune_Tolerant
- Control_vs_Immune_Tolerant
- Control_vs_Immune_Tolerant
- Calu3_Mock_DMEM_vs_Calu3_10uM_NIC
- Control_vs_Day_12
- Control_vs_Paramycin
- Solanum_habrochaites_leaf_vs_glandular_trichome
- Sham_vs_UIR
- Sham_vs_UIR
- Control_14dpi_vs_Infected_14dpi
- Control_14dpi_vs_Infected_14dpi
- Normal_control_no_tumor_vs_FH_deficient_RCC
- Hindgut_Control_vs_Lactobacillus_apis
- Embryo_S1_vs_Embryo_S4
- Untreated_vs_Antibiotic_Treated
- Untreated_vs_Antibiotic_Treated
- Control_vs_Endometrial_Cancer
- G1_Control_vs_G2_Arginine_Addition
- AMAD_Log_vs_AMAE_Sta
- Control_No_Glycine_vs_SHMT2_Upregulated_No_Glycine
- Sham_vs_Radiofrequency
- Healthy_Control_vs_Osteoarticular_Tuberculosis
- Healthy_Control_vs_Psoriatic_Arthritis
- Glu_BW25113_vs_Pyr_BW25113
- Uninfected_BALB/c_vs_Plasmodium_yoelii_17XL_BALB/c
- Control_vs_150mM
- Control_vs_150mM
- Wild_type_vs_Knock_out
- Wild_Type_vs_Gene_Knockout
- Purple_vs_Green
- Control_vs_CSD
- Healthy_vs_RAS4
- Normal_Diet_vs_High-fat_Diet
- Normal_Diet_vs_High-fat_Diet
- Normal_Diet_vs_High-fat_Diet
- Control_vs_150mM
- CIDP_patient_vs_healthy_control
- Control_0h_vs_GABA_0h
- Control_vs_Fermented_Mulberry_Leaves
- Col_ND_15h_vs_Col_ND_27h
- Control_vs_Lactic_Acid
- Control_vs_TGF-beta_Treatment
- Control_vs_BP3_Low_Concentration
- ASD_Fecal_vs_TD_Fecal
- Inbreeding_Growth_Chamber_0_day_vs_Inbreeding_Growth_Chamber_92_day
- WT_vs_MPK1_Mutant